跳转至内容
Merck

Y0001137

丁酸氯倍他松

European Pharmacopoeia (EP) Reference Standard

别名:

Clobetasone butyrate, 21-Chloro-9-fluoro-17-hydroxy-16-methylpregna-1,4-diene-3,11,20-trione 17-butyrate

登录查看公司和协议定价

选择尺寸

20 MG
$223.00

$223.00


预计发货时间2025年3月17日详情


获取大包装报价

选择尺寸

变更视图
20 MG
$223.00

About This Item

经验公式(希尔记法):
C26H32ClFO5
CAS号:
分子量:
478.98
MDL號碼:
分類程式碼代碼:
41116107
PubChem物質ID:
NACRES:
NA.24

$223.00


预计发货时间2025年3月17日详情


获取大包装报价

等級

pharmaceutical primary standard

API 家族

clobetasone

製造商/商標名

EDQM

應用

pharmaceutical (small molecule)

形式

neat

儲存溫度

2-8°C

SMILES 字串

CCCC(=O)O[C@@]1([C@@H](C)C[C@H]2[C@@H]3CCC4=CC(=O)C=C[C@]4(C)[C@@]3(F)C(=O)C[C@]12C)C(=O)CCl

InChI

1S/C26H32ClFO5/c1-5-6-22(32)33-26(21(31)14-27)15(2)11-19-18-8-7-16-12-17(29)9-10-23(16,3)25(18,28)20(30)13-24(19,26)4/h9-10,12,15,18-19H,5-8,11,13-14H2,1-4H3/t15-,18-,19-,23-,24-,25-,26-/m0/s1

InChI 密鑰

FBRAWBYQGRLCEK-AVVSTMBFSA-N

正在寻找类似产品? 访问 产品对比指南

一般說明

This product is provided as delivered and specified by the issuing Pharmacopoeia. All information provided in support of this product, including SDS and any product information leaflets have been developed and issued under the Authority of the Issuing Pharmacopoeia. For further information and support please go to the website of the issuing Pharmacopoeia.

應用

Clobetasone butyrate for system suitability EP Reference standard, intended for use in laboratory tests only as specifically prescribed in the European Pharmacopoeia.

包裝

The product is delivered as supplied by the issuing Pharmacopoeia. For the current unit quantity, please visit the EDQM reference substance catalogue.

其他說明

Sales restrictions may apply.

儲存類別代碼

11 - Combustible Solids

水污染物質分類(WGK)

WGK 3

閃點(°F)

Not applicable

閃點(°C)

Not applicable


历史批次信息供参考:

分析证书(COA)

Lot/Batch Number

It looks like we've run into a problem, but you can still download Certificates of Analysis from our 文件 section.

如需帮助,请联系 客户支持

已有该产品?

在文件库中查找您最近购买产品的文档。

访问文档库

Acute anterior uveitis.
Andreé Curi et al.
Clinical evidence, (9)(9), 691-696 (2004-09-16)
A Parneix-Spake et al.
The Journal of dermatological treatment, 12(4), 191-197 (2002-09-21)
The emollient base of a topical corticosteroid, through its moisturizing properties, can be a useful treatment adjunct. To compare the healing properties of Eumovate trade mark (clobetasone butyrate) 0.05% cream with its emollient base, hydrocortisone 1% cream and with no
Ingestion of topical steroid triggering pustular psoriasis?
S D Orpin et al.
The British journal of dermatology, 153(3), 680-682 (2005-08-27)
Sweet's syndrome masquerading as figurate erythema.
Barbara Behm et al.
International journal of dermatology, 51(9), 1101-1103 (2012-02-11)
Stephen Shei Dei Yang et al.
The Journal of urology, 173(4), 1361-1363 (2005-03-11)
We report a prospective randomized study comparing the effects of highly potent and moderately potent topical steroids in treating pediatric phimosis. A total of 70 boys 1 to 12 years old with phimosis were randomly assigned to receive topical application

Questions

Reviews

No rating value

Active Filters

我们的科学家团队拥有各种研究领域经验,包括生命科学、材料科学、化学合成、色谱、分析及许多其他领域.

联系技术服务部门